SCHEMBL8364218

SCHEMBL8364218

COC(=O)c1ccc(CN(C2CCCN(C(=O)N3CCOCC3)C2)S(=O)(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.48
HIF1A Q16665 1/20 0.48
HSD17B10 Q99714 2/20 0.43
KDM4E B2RXH2 1/20 0.43
PSEN1 P49768 5/20 0.42
PSEN2 P49810 5/20 0.42
APH1B Q8WW43 5/20 0.42
NCSTN Q92542 5/20 0.42
APH1A Q96BI3 5/20 0.42
PSENEN Q9NZ42 5/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 1/20 0.42
AKR1C3 P42330 2/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
RORC P51449 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8363917 0.94 MEN1 (0.45) EP300HIF1AHSD17B10KDM4EPSEN1
SCHEMBL8364235 0.90 EP300 (0.45) EP300HIF1AHSD17B10KDM4EPSEN1
SCHEMBL8363935 0.89 MEN1 (0.46) EP300HIF1AHSD17B10KDM4EPSEN1
SCHEMBL8364321 0.86 KDM4E (0.45) HSD17B10KDM4EPSEN1PSEN2APH1B
SCHEMBL8364220 0.85 MEN1 (0.45) EP300HIF1AHSD17B10KDM4EPSEN1
SCHEMBL8360870 0.85 NR1D1 (0.48) HSD17B10KDM4EPSEN1PSEN2APH1B
SCHEMBL8363845 0.84 LMNA (0.49) HSD17B10KDM4EPSEN1PSEN2APH1B
SCHEMBL8364270 0.84 PSEN1 (0.44) HSD17B10KDM4EPSEN1PSEN2APH1B
SCHEMBL14842437 0.84 HDAC8 (0.50) EP300HIF1AHSD17B10KDM4EPSEN1
SCHEMBL8364319 0.83 MAPT (0.49) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003013527-A1 SULFONAMIDE DERIVATIVES AS GAMMA SECRETASE INHIBITORS SCHERING CORPORATION (US) 2003-02-20 WO disclosed